It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

ANX005 in Guillain-Barré syndrome (GBS): First-in-kind monoclonal antibody designed to block C1q and the entire classical complement pathway in both the body and the brain has the potential to be the ...

The deal is expected to provide SPIMACO with a significant opportunity to strengthen its product portfolio, enhance its ...

As a state-of-the-art pharmaceutical manufacturing facility, the Couvet site plays a vital role in WuXi AppTec's CRDMO business model by providing both clinical and commercial scale manufacturing ...

AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

Based on its chemical properties, Pharvaris is developing two formulations of deucrictibant for oral administration: an extended-release tablet to enable sustained absorption and efficacy in ...

Key features: Composed of Gluten free formula Contains 600 IU in each tablet Vegan & Non-GMO ... for people who want to ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Similarly, a study at Michigan State University revealed that after only 10 hours of study with Babbel, 9 6% of learners ...

Medically reviewed by Mary Choy, PharmD Amlodipine is a commonly prescribed calcium channel blocker medication used to treat ...

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, ...

Continuing to advance the pipeline and remain on-track to engage with the FDA on TP-04 (Papulopustular Rosacea) and TP-05 ...